Compare LACTOSE INDIA with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs CADILA HEALTHCARE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LACTOSE INDIA CADILA HEALTHCARE LACTOSE INDIA/
CADILA HEALTHCARE
 
P/E (TTM) x -81.2 19.5 - View Chart
P/BV x 1.3 3.5 35.4% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 LACTOSE INDIA   CADILA HEALTHCARE
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-21
CADILA HEALTHCARE
Mar-21
LACTOSE INDIA/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs42509 8.2%   
Low Rs16259 6.2%   
Sales per share (Unadj.) Rs30.6147.5 20.7%  
Earnings per share (Unadj.) Rs-2.220.9 -10.4%  
Cash flow per share (Unadj.) Rs1.628.0 5.9%  
Dividends per share (Unadj.) Rs03.50 0.0%  
Avg Dividend yield %00.9 0.0%  
Book value per share (Unadj.) Rs30.1126.9 23.8%  
Shares outstanding (eoy) m11.441,023.74 1.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.92.6 36.3%   
Avg P/E ratio x-13.318.4 -72.5%  
P/CF ratio (eoy) x17.613.7 127.9%  
Price / Book Value ratio x1.03.0 31.7%  
Dividend payout %016.8 0.0%   
Avg Mkt Cap Rs m330393,092 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m10622,548 0.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m350151,022 0.2%  
Other income Rs m3449 0.7%   
Total revenues Rs m353151,471 0.2%   
Gross profit Rs m6231,335 0.2%  
Depreciation Rs m447,248 0.6%   
Interest Rs m541,688 3.2%   
Profit before tax Rs m-3322,848 -0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-81,472 -0.5%   
Profit after tax Rs m-2521,376 -0.1%  
Gross profit margin %17.820.7 85.8%  
Effective tax rate %24.26.4 376.4%   
Net profit margin %-7.114.2 -50.1%  
BALANCE SHEET DATA
Current assets Rs m19787,160 0.2%   
Current liabilities Rs m11678,613 0.1%   
Net working cap to sales %23.15.7 408.2%  
Current ratio x1.71.1 152.9%  
Inventory Days Days5933 177.4%  
Debtors Days Days67176 887.9%  
Net fixed assets Rs m686140,943 0.5%   
Share capital Rs m1141,024 11.2%   
"Free" reserves Rs m230128,899 0.2%   
Net worth Rs m345129,923 0.3%   
Long term debt Rs m3936,095 6.4%   
Total assets Rs m883228,103 0.4%  
Interest coverage x0.414.5 2.8%   
Debt to equity ratio x1.10 2,427.1%  
Sales to assets ratio x0.40.7 59.8%   
Return on assets %3.410.1 33.3%  
Return on equity %-7.216.5 -43.7%  
Return on capital %3.018.0 16.4%  
Exports to sales %00-   
Imports to sales %7.410.5 70.4%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m2615,911 0.2%   
Fx inflow Rs m2563,535 0.0%   
Fx outflow Rs m2715,911 0.2%   
Net fx Rs m-247,624 -0.0%   
CASH FLOW
From Operations Rs m2232,930 0.1%  
From Investments Rs m-62-7,225 0.9%  
From Financial Activity Rs m45-25,489 -0.2%  
Net Cashflow Rs m5-905 -0.6%  

Share Holding

Indian Promoters % 49.1 74.9 65.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.7 15.4 4.4%  
FIIs % 0.0 4.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 50.9 25.1 202.5%  
Shareholders   15,737 351,595 4.5%  
Pledged promoter(s) holding % 47.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LACTOSE INDIA With:   GUJ.THEMIS.  DENIS CHEM LAB  ALKEM LABORATORIES  JENBURKT PH.  DISHMAN CARBOGEN AMCIS  



Today's Market

Sensex Snaps 2-Day Losing Streak, Zooms 887 Points, Nifty Settles Above 17,150; Tata Steel, Axis Bank Top Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (1QFY22); Net Profit Up 35.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, CADILA HEALTHCARE has posted a net profit of Rs 6 bn (up 35.0% YoY). Sales on the other hand came in at Rs 40 bn (up 14.5% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2020-21 Annual Report Analysis (Annual Result Update)

Aug 10, 2021 | Updated on Aug 10, 2021

Here's an analysis of the annual report of CADILA HEALTHCARE for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

Cadila Healthcare Reports 73% Rise in Profits (Views On News)

May 28, 2021

A look into the company's quarter four financial performance.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LACTOSE INDIA SHARE PRICE


Dec 7, 2021 (Close)

TRACK LACTOSE INDIA

  • Track your investment in LACTOSE INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LACTOSE INDIA - BAL PHARMA COMPARISON

COMPARE LACTOSE INDIA WITH

MARKET STATS